CTOs on the Move

Enara Health

www.enarahealth.com

 
Enara Health is building a data-driven platform and network to scale obesity treatment. Based in San Mateo, Calif., and operating since March 2015, Enara Health offers unique hybrid digital and in-person weight loss programs based on precision medicine. By combining mobile technology with health care visits and providing patients with personalized physician-driven medical weight loss programs, Enara Health routinely helps patients lose—and keep off—more than 15% of their baseline weight, which is far greater than the results seen with other m-health interventions.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.enarahealth.com
  • 3050 South Delaware Street Suite 130
    San Mateo, CA USA 94403
  • Phone: 650.319.8654

Executives

Name Title Contact Details
Felipe Baytelman
Chief Technology Officer Profile

Similar Companies

Terracina Grand

Terracina Grand is a Naples, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

New Century Health

New Century Health delivers specialty care management solutions that leverage technology and evidence-based medicine at the point-of-care, with a focus on oncology and cardiology. Our services promote the most effective treatment, reduce variability, improve clinical outcomes, and optimize cost-effectiveness.

The Guild

Whether you travel because you want to or because you have to, being away from home shouldn`t mean pressing pause on life. With the comforts of the community, the pleasures of home, and the perks of prime locations, The Guild lets you keep on living your best life--no matter where the road takes you.

Labopharm

Labopharm Inc. is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Labopharm Inc. is based in Laval, QC. You can find more information on Labopharm Inc. at www.labopharm.com

Kite Pharma

Kite Pharma, founded in 2009, is dedicated to the development and commercialization of novel cancer immunotherapy products designed to harness the power of a patient’s own immune system to fight tumor cells. Kite’s lead programs are in collaboration with the National Cancer Institute (NCI) and are being studied through the NCI’s Surgery Branch led by Steven A. Rosenberg, MD, PhD, who has pioneered immunotherapy approaches for cancer for more than two decades. This research has resulted in breakthrough clinical findings, including results from an NCI Phase 1/2a trial being presented at this year’s American Society of Hematology (ASH) Annual Meeting. Based on this progress and momentum, Kite plans to initiate a company-sponsored multicenter clinical program in aggressive non-Hodgkin’s lymphoma, with additional filings expected for other eACT™ products in diverse oncology indications.